Ironwood Pharmaceuticals

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$106,506
$47,709
$122,060
$85,239
Gross Profit
106,063
47,249
122,060
85,239
EBITDA
72,976
8,801
76,929
46,645
EBIT
72,533
8,341
76,454
46,178
Net Income
89,571
-2,276
40,080
23,599
Net Change In Cash
106,506
47,709
122,060
85,239
Free Cash Flow
5,121
74,576
47,581
-15,070
Cash
220,471
215,456
140,407
92,852
Basic Shares
166,690
177,764
177,764
161,723

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$296,151
$351,410
$442,735
$410,596
Gross Profit
294,270
343,858
436,587
409,178
EBITDA
104,652
97,728
197,411
261,438
EBIT
102,771
95,717
195,836
260,020
Net Income
24,017
880
-1,002,239
175,065
Net Change In Cash
296,151
351,410
442,735
410,596
Cost of Revenue
36,074
Free Cash Flow
127,010
103,407
183,154
273,627
Cash
215,456
88,559
92,154
656,203
Basic Shares
177,764
160,084
155,435
186,312

Earnings Calls

QuarterEPS
2026-03-31
$0.24
2025-12-31
-$0.01
2025-09-30
$0.24
2025-06-30
$0.14